EUVIMEDEUVIMED entdecken
Crossref

PPT1 regulates mitochondrial redox by depalmitoylating PRDX3

Gengjun Zhu, Lifang Jin, Weizhang Shen, Xiaofeng Li, Xing Tian, Yuhua Zhang, Ning Liu

Cellular Signalling · 2026

DOI: 10.1016/j.cellsig.2026.112502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cellular Signalling, 2026. Verfasst von Gengjun Zhu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory, The Second Hospital of Jilin University, Changchun 130041, PR China. Hauptthemen laut MEDLINE: Peroxiredoxin III, Mitochondria, Multiple Myeloma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Jilin Provincial Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple myeloma (MM) remains an incurable hematological cancer, with an enhanced antioxidant capacity that fuels disease progression. Peroxiredoxins (PRDXs), central players of redox homeostasis, are overexpressed in cancers including MM, and their high expression correlates with poor prognosis. However, the detailed mechanisms underlying how PRDXs are regulated in the context of redox homeostasis and MM pathogenesis remain unclear. In this study, we identify PPT1 as a promising therapeutic target that sustains PRDX3 antioxidant activity by catalyzing its depalmitoylation at the catalytic cysteine (C108). We demonstrated that genetic or chemical inhibition of PPT1 induced cytotoxicity in MM cells through a mechanism involving elevated mitochondrial reactive oxygen species (mtROS). Furthermore, PPT1 inhibition significantly suppressed the growth of xenograft tumors and increased the level of PRDX3 S-palmitoylation. Collectively, our study identifies PPT1 as the bona fide depalmitoylase of PRDX3 and establishes this axis as a promising therapeutic target in MM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peroxiredoxin IIIMitochondriaMultiple MyelomaHumansOxidation-ReductionAnimalsReactive Oxygen SpeciesCell Line, TumorMice

Stichwörter der Autor:innen

DepalmitoylationMitochondrial redox homeostasisMultiple myelomaPPT1PRDX3

Substanzen

Peroxiredoxin IIIPRDX3 protein, humanReactive Oxygen Species

Autor:innen und Institutionen

  • Central Laboratory, The Second Hospital of Jilin University, Changchun 130041, PR China.
  • Department Oncology and Hematology, The Second Hospital of Jilin University, Changchun 130041, PR China.
  • Central Laboratory, The Second Hospital of Jilin University, Changchun 130041, PR China; Key Laboratory of Zoonosis Research, Ministry of Education, Jilin University, Changchun 130041, PR China. Electronic address: liu_…

Förderung

  • Jilin Provincial Natural Science Foundation

Zitieren

APA

Zhu, G., Jin, L., Shen, W., Li, X., Tian, X., Zhang, Y., & Liu, N. (2026). PPT1 regulates mitochondrial redox by depalmitoylating PRDX3. Cellular Signalling. https://doi.org/10.1016/j.cellsig.2026.112502

Vancouver

Zhu G, Jin L, Shen W, Li X, Tian X, Zhang Y, et al. PPT1 regulates mitochondrial redox by depalmitoylating PRDX3. Cellular Signalling. 2026. doi:10.1016/j.cellsig.2026.112502

BibTeX
@article{Zhu2026,
  author = {Zhu, Gengjun and Jin, Lifang and Shen, Weizhang and Li, Xiaofeng and Tian, Xing and Zhang, Yuhua and Liu, Ning},
  title = {PPT1 regulates mitochondrial redox by depalmitoylating PRDX3},
  journal = {Cellular Signalling},
  year = {2026},
  doi = {10.1016/j.cellsig.2026.112502}
}
Kostenlos starten →